NCT05060237 2024-10-17Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and ScalpBiofrontera Bioscience GmbHPhase 1 Completed112 enrolled 21 charts